Minghui Pharmaceutical gets FDA green light for Phase III trials of its therapy in thyroid eye disease
The upcoming trials will evaluate both active and chronic TED in randomized, double-blind, placebo-controlled studies
The upcoming trials will evaluate both active and chronic TED in randomized, double-blind, placebo-controlled studies
The topical fluralaner solution is cleared for the prevention and treatment of new world screwworm infestation
It's a development that marks a major step forward for patients struggling with moderate-to-severe chronic spontaneous urticaria
The cleared system pairs a flexible nitinol implant with a deployable prong-locking mechanism, delivering rotational and length stability
The FDA is initiating removal of the boxed warnings following a comprehensive review of the scientific literature
Phase 1 has a total reactor capacity of 440 kL with 63 reactors
The 27 greenfield labs across the country ensure timely and accurate reporting
The partnership provides Sai Life Sciences with a greenhouse gas emissions reduction of up to 90% for its international logistics needs by using SAF
Subscribe To Our Newsletter & Stay Updated